Related Experiment Video

Updated: May 23, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Miz1 is a critical repressor of cdkn1a during skin tumorigenesis

Jan Hönnemann1, Adrián Sanz-Moreno, Elmar Wolf

  • 1Department of Cytobiology, Philipps-University Marburg, Germany.

Plos One
|April 18, 2012
PubMed

Insights

The transcription factor Miz1 restrains skin tumor development by repressing cell cycle arrest pathways. Miz1

Area of Science:

  • Molecular biology
  • Oncology
  • Dermatology

Background:

  • Miz1 transcription factor forms repressive complexes with oncoproteins like Myc.
  • Known Miz1 target genes include cyclin-dependent kinase inhibitors (CKIs) such as cdkn2b and cdkn1a.
  • The role of Miz1-mediated repression in in vivo cell proliferation and tumor formation remains unclear.

Purpose of the Study:

  • To investigate the role of Miz1 in skin tumor development and cell proliferation in vivo.
  • To determine if Miz1-mediated repression of CKIs is critical for tumorigenesis.

Main Methods:

  • Utilized a mouse model of chemically-induced, Ras-dependent skin tumorigenesis.
  • Generated mice with a deletion of the Miz1 POZ domain, critical for its function.
  • Analyzed epidermal differentiation and keratinocyte proliferation in response to TPA.
  • Examined the impact of cdkn1a and cdkn2b deletion on tumorigenesis and differentiation.

Main Results:

  • Deletion of the Miz1 POZ domain restrained skin tumor development.
  • Miz1-deficient keratinocytes showed reduced proliferation and accelerated differentiation upon TPA treatment.
  • Tumorigenesis, proliferation, and differentiation were restored in mice lacking cdkn1a, but not cdkn2b.

Conclusions:

  • Miz1-mediated repression of cdkn1a is crucial for attenuating cell cycle arrest pathways during skin tumorigenesis.
  • Miz1 plays a critical role in regulating keratinocyte proliferation and differentiation in the context of skin cancer.

More Related Videos

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia08:14

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia

Published on: July 25, 2017

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.